Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
Open Access
- 1 January 2016
- journal article
- review article
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 40 (1) , 1-11
Abstract
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in adults and children worldwide. NAFLD has become a severe health issue and it can progress towards a more severe form of the disease, the non-alcoholic steatohepatitis (NASH). A combination of environmental factors, host genetics, and gut microbiota leads to excessive accumulation of lipids in the liver (steatosis), which may result in lipotoxicity and trigger hepatocyte cell death, liver inflammation, fibrosis, and pathological angiogenesis. NASH can further progress towards liver cirrhosis and cancer. Over the last few years, cell-derived extracellular vesicles (EVs) have been identified as effective cell-to-cell messengers that transfer several bioactive molecules in target cells, modulating the pathogenesis and progression of NASH. In this review, we focused on recently highlighted aspects of molecular pathogenesis of NASH, mediated by EVs via their bioactive components. The studies included in this review summarize the state of art regarding the role of EVs during the progression of NASH and bring novel insight about the potential use of EVs for diagnosis and therapeutic strategies for patients with this disease.Keywords
Funding Information
- National Institutes of Health (U01 AA022489, R21 AA023574)
- American Liver Foundation
This publication has 102 references indexed in Scilit:
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cellsHepatology, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Liver Cell–Derived Microparticles Activate Hedgehog Signaling and Alter Gene Expression in Hepatic Endothelial CellsGastroenterology, 2009
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionHepatology, 2008
- Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver DiseaseCirculation, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicityHepatology, 2007